Bio-Optronics Releases New Version of CTMS Technology - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
Bio-Optronics Releases New Version of CTMS Technology

Source: Applied Clinical Trials

Bio-Optronics' Clinical Conductor CTMS team announced new features in the latest release of Clinical Conductor, one of which is multiple CTMS configuration flexibility. These configurations are designed for research sites, site networks, CROs, hospitals, health systems and sponsors feature sets and functionalities required by their specific organization.

In addition to the configurations in this release, Clinical Conductor includes more financial functionality to give organizations even greater insight into their study finances.

Read the full release here.

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

UPCOMING CONFERENCES

8th Annual Forum on Transparency and Aggregate Spend 2014
Washington, DC
August 18-20, 2014

eSource Data in Clinical Investigations
Philadelphia, PA
August 20-21, 2014

Pharmacovigilance 2014
Philadelphia, PA
September 10-11, 2014

Collaborative Research Summit
Philadelphia, PA
October 15-16, 2014

See All Conferences >>

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
86%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
7%
View Results
Untitled Document
Source: Applied Clinical Trials,
Click here